跳至主要内容
临床试验/CTRI/2013/02/003380
CTRI/2013/02/003380已完成未知

A prospective, non-interventional, cohort survey on VTE risk in patients receiving new chemotherapy for cancer - CANTARISK

Sanofi Synthelabo India Ltd0 个研究点目标入组 4,300 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
4,300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients with:
  • colorectal or lung (SCLC or NSCLC) cancer, cytologically or histologically confirmed,
  • metastatic or locally advanced,
  • and about to start a new chemotherapy
  • Age >= 18 years
  • Written informed consent

排除标准

  • Patients on:
  • Current or anticipated anticoagulant use with exception of use to maintain patency of central venous catheter only.
  • Life expectancy < 4 months
  • Patients participating or planned to be enrolled in clinical trials with blinded study therapy

研究者

发起方
Sanofi Synthelabo India Ltd

相似试验